Biosignis

Annecy, France

Clinical Data Management Clinical Research Laboratory Testing Diagnostics

The management of human biological samples and associated analyses represents a major challenge in scientific and medical research. Often, the availability of samples is not necessarily accompanied by complete analytical data. The search for competent laboratories to test kits, perform analyses on samples, or set up a human-involved research (HIPR) to create a cohort becomes complex. In addition, the search for data can be hampered by gaps in the necessary parameters, and conducting multisite performance studies can be a laborious process.

✓Source: HealthTech Alpha by Galen Growth

Shareable draft

Check out Biosignis on @MedStartr Today #AllTherapeuticAreas #ClinicalDataManagement #ClinicalResearch #LaboratoryTesting #Diagnostics #MedMo #MedStartrVentures

https://www.medstartr.ai/s/RqiD8FjVthk

Get Involved in Biosignis

🏢Is this your company? Claim This Profile

Join MedStartr to verify with your work email and edit this profile

Company Info

Founded: 2022
Website: dynamique-orion.com/

Disease Areas

All Therapeutic Areas

Technologies

Biorepository ScienceBiological Data ManagementLaboratory TechnologyAssay Technology

🌐Website

What do you think of Biosignis?

A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.

Clinical Benefit Potential

The potential for a project to have a large and significant impact on medical care, treatment, or prevention.

Feasibility

The likelihood that this will provide benefit for patients / care givers and that the founders can execute on their vision and plan.

Innovativeness

The distinguishing features, concept, or technology that differentiates the entry compared to others that already exist and are in widespread use.

Fundability

The reviewers' beliefs that the idea is fundable or can make it to sustainability without outside investment.

Scalability

Some great ideas are destined to failure because they are too complex or too expensive. The reviewer should consider the likelihood that a project as explained, or perhaps with some tweaks, could possibly become a worldwide solution within a reasonable time frame.

Presentation Quality

How well the team presented the idea.

Submit anonymously — my name won't be shown to the team or on this profile

Your scores and comments are shown with your review on this company's profile.